Linagliptin Methyldimer (>85%)

Impurity Linagliptin Dimer Impurity Stability Light Sensitive Applications Linagliptin Methyldimer inhibits dipeptidylpeptidase-IV (DPP-IV) and may be used in the treatment of type 2 diabetes. References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);